We have screened the whole genome for linkage in 40 Italian multiplex families with multiple sclerosis using 322 markers. The GENEHUNTER-PLUS program was used to analyse these data and revealed eight regions of potential linkage where the lod score exceeds the nominal 5% significance level (0.7). No region of linkage with genome-wide significance was identified and none of the markers showed evidence of statistically significant transmission disequilibrium. Overall these results have refined the linkage data relating to this disease in Italians modestly supporting some previously identified areas of interest and helping to exclude others. Genes and Immunity (2001) 2, 205-210.
Introduction
It is well established that genetic factors influence susceptibility to multiple sclerosis 1 but, the responsible genes remain largely undefined, association with class II alleles of the MHC being the only established genetic feature of the disease. In recent years, developments in the human genome project [2] [3] [4] [5] [6] have enabled researchers to perform systematic searches for linkage in complex diseases where the genetic effects attributable to involved genes are modest and therefore very large genotyping efforts are required. To date, four such whole genome linkage screens have been completed in multiple sclerosis. [7] [8] [9] [10] Although none of these screens succeeded in identifying statistically unequivocal linkage, each suggested several regions of potential linkage and together they provide the best available summary of the likely location of the relevant genes. 11 In considering these screens, it is important to remember that the power of this approach is critically dependant upon the frequency of susceptibility alleles in the population studied. 12 Despite the failure of previous linkage screens to solve the basis for genetic susceptibility in multiple sclerosis, the approach is still worth pursuing in populations where the frequency of susceptibility alleles might be more favourable.
The prevalence of multiple sclerosis in Italy is approximately 56 per 100 000 and this is intermediate between the rates seen in northern Europe and those seen in north Africa. 13, 14 While this intermediate rate of disease might be the result of environmental factors, variation in the frequency of susceptibility alleles is a more likely explanation. 15 These observations suggest that, for some loci, linkage studies based on Italian families might have greater power than those based on families from populations with higher rates of disease where the normal frequency of susceptibility alleles may be disadvantageous. Working on this principle we have previously searched for genetic linkage to multiple sclerosis in Italian families, concentrating on those regions of the genome suggested to be the most promising in existing linkage screens. 16 Since the results of this analysis revealed a degree of concordance with previous screens but left most of the genome unexplored, we have now extended the analysis of Italian families to include the remainder of the genome.
Results and discussion
The 40 families considered in this screen included 37 with two affected siblings, one with three affected siblings and two with two affected first cousins. Our previous study 16 involved 36 of these families (34 of the sibling pairs, one of the cousin pairs and the sibling trio) together with three additional sibling pair families, an additional cousin pair and an uncle/nephew pair; unfortunately Figure 1 The lod score calculated by GENEHUNTER-PLUS 18, 19 at each point along the genome is indicated, one graph for each chromosome. The length of each x-axis is proportional to the genetic length of the corresponding chromosome and the map position of the markers is indicated by the tick marks. Marker names are placed as near as possible to their appropriate tick mark within the limits of clarity; tick marks for markers with less than 2 cM separation have in some instances been superimposed. The y-axis is scaled from 0 to 1.5 in each case. The families and markers considered in this screen overlap with those included in our previous study. 16 The mean observed heterozygosity for the 322 markers was 79% and their mean PIC was 76%. The genetic position of each marker was established from the location database (LDB, http://cedar.genetics.soton.ac.uk/publicFhtml/) 24 except for markers not included in this database which were placed midway between their flanking markers as derived from the map of Davies et al. 25 Because only small quantities of genomic DNA were available on each individual, a polymerase extension PCR (PEP) protocol was used non-specifically to amplify individual DNA samples prior to genotyping. 26 Genotyping was then achieved by PCR amplification of each microsatellite followed by electrophoresis on Applied Biosystems 373A sequencing machines, with allele sizing and calling being performed using GENESCAN and GENOTYPER software (Perkin-Elmer, Foster city, CA, USA). Allele frequencies used in the analysis were derived from the data using the SPLINK program version 1.
insufficient DNA was available from these additional five families to allow their inclusion in this extended study. The four new families included three with two affected siblings and one with two affected cousins. A total 322 markers (321 microsatellites and HLA-DRB1) were used.
In our previous study 16 we typed just 67 microsatellite markers (together with HLA-DRB1 and APOE). Only 42 of these 67 microsatellite markers are re-included in the current analysis; the remaining 25 were omitted in order to avoid distorting the marker map, a process which can 17 Analysis of these overlapping 42 markers was extended to include the four families not previously typed. All 40 families were typed for the 279 new microsatellite markers.
The results of multipoint nonparametric linkage analysis on each chromosome are shown in Figure 1 . The analysis was performed using GENEHUNTER-PLUS. 18, 19 Although there are no regions suggestive of linkage with genome-wide statistical significance, 20 eight regions were identified where the lod score exceeds 0.7 (the nominal 5% significance level), chromosomes 1q42, 1q44, 2q36, 5q33, 6pter, 6q22, 10cen and 15q21. The conservative interpretation is that the number and size of the linkage peaks seen in this screen do not exceed chance expectation.
The extent to which the markers have extracted the available genetic information from these 40 families was also tested by GENEHUNTER-PLUS. Average information content across the genome was 51%, ranging from 89% where informative markers were typed to 8% where no markers were typed such as the short arm of chromosome 22.
Each of the microsatellite markers was tested for evidence of transmission disequilibrium using the TRANS-MIT program. Five markers (D2S169, D4S406, D8S257, D22S21 and DXS991) showed evidence of transmission disequilibrium at the nominal 5% significance level. However after correcting for multiple testing none of these potential associations was statistically significant.
In summary, we have completed a genome-wide screen for linkage in Italian families with multiple sclerosis, several regions of interest have been identified but none of these have genome-wide statistical significance. The previous linkage genome screens in multiple scler- 7-10 used populations of northern European descent and clearly demonstrated that, in these populations, the effect of individual genes determining susceptibility to multiple sclerosis is modest. 21, 22 It remained possible that in a southern European population the frequency of susceptibility alleles might be more favourable 12 and thereby enable linkage to be identified with greater ease.
That this is not the case has several possible explanations. The modest number of families considered means that the power of our study is low, making it possible for important effects easily to be missed and suggesting that our statistically negative results could represent a type II error. We had hypothesised that the lower frequency of multiple sclerosis in southern Europeans might reflect a lower frequency of susceptibility alleles in this population. We further hypothesised that this might result in southern European populations being more favourable for linkage analysis. Tacit in this hypothesis is the suggestion that the susceptibility alleles for some genes have frequencies in northern Europeans that are prohibitively high (Ͼ90%). However it is possible that susceptibility allele frequencies in northern Europeans are more modest (20-80%) and by moving to a southern European population we have simply reduced them to an even less favourable position (Ͻ10%). If this is the case, then the southern European population offers no special advantage in terms of power. Unfortunately the power of our present study is too limited to know which of these possibilities is correct.
Despite the limitations, the peaks of linkage we have observed show some concordance with results from other studies. Perhaps the most interesting result is that on chromosome 10cen, which is close to a region previously identified in the multiple sclerosis genome screen of
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Haines et al 8 and broadly corresponds to the location of the iddm10 locus, 23 suggesting that a gene conferring risk to autoimmunity in general may be encoded at this locus. The result in the region of HLA is as expected. The association of class II HLA alleles with multiple sclerosis is well known but the effect of this locus on susceptibility is modest and therefore evidence for linkage also expected to be small, as in the previous genome screens. [7] [8] [9] [10] In considering how this new screen contributes to our understanding of previously suggested regions of interest it is important to remember that, in such a small study, any positive lod score can be considered to be supportive, even if it is not statistically significant. Modest but genuine effects which have previously generated results that are only just significant would be expected to be even less obvious in smaller replicate analyses, whereas false positive results would be more likely to show zero lod scores. Furthermore, linkage peaks can be quite ectopic relative to the location of the causative gene. Similarly the limited power of this study means that we cannot confidently rule out the possibility that projects based on modest risk populations may be better able to detect susceptibility genes than those based on high risk populations.
Although additional strategies are being developed, family-based linkage genome screening can still make important contributions to the genetic analysis of complex traits such as multiple sclerosis and the continued expansion of such linkage data should be encouraged. Comparing and contrasting the growing body of linkage screens will undoubtedly aid in the reliable identification of genomic regions containing susceptibility genes.
